Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119846
Chunk: 33

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 33
---
                                                  |

Corporate Information We were incorporated under the name “Vickers Vantage Corp. I” on February 21, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. On November 9, 2022, we changed our jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware. On November 9, 2022, we changed our name to “Scilex Holding Company”. Our principal executive offices are located at 960 San Antonio Road, Palo Alto, California 94303, and our telephone number is (650) 516-4310.Our website address is www.scilexholding.com. Any information contained on, or that can be accessed through, our website is not incorporated by reference into, nor is it in any way part of this prospectus and should not be relied upon in connection with making any decision with respect to an investment in our securities. We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. You may obtain any of the documents filed by us with the SEC at no cost from the SEC’s website at http://www.sec.gov.

19

THE OFFERING Issuance of Common Stock

| Shares of Common Stock offered by us | Up to 198,810 shares, issuable upon the exercise of (i) 1,402,955 Private Warrants by the holders thereof and (ii) 5,555,354 Public Warrants by the holders thereof. |

| Shares of Common Stock outstanding prior to exercise of all SPAC Warrants(1) | 6,951,671 shares of Common Stock (as of March 31, 2025). |

| Shares of Common Stock outstanding assuming exercise of all SPAC Warrants | 7,150,481 shares (based on total shares of Common Stock outstanding as of March 31, 2025). |

| Exercise price of SPAC Warrants | $402.50 per whole share, subject to adjustment as described herein. |

| Use of Proceeds | We will receive up to an aggregate of approximately $80.0 million from the exercise of the SPAC Warrants, consisting of up to 1,402,955 Private Warrants and up to 5,555,354 Public W